Live
- AAP Announces Final Candidate List For 2025 Delhi Assembly Elections, Kejriwal To Contest From New Delhi
- Bangladesh unrest has delayed execution of some vital projects: Tripura CM
- PIL in SC seeks direction to designate BMC as sole planning, sanctioning authority for Mumbai
- 3rd Test: Centuries from Head, Smith help dominant Australia feast on listless India
- AAP final list of 38 names in Delhi: Kejriwal, CM Atishi retain seats
- Tributes Paid to Sardar Vallabhbhai Patel on His Death Anniversary at CM Revanth Reddy's Residence
- In just one year, Bhajanlal govt wins hearts of people
- CM Chandrababu announces establishment of Potti Sriramulu Telugu University
- Sutume, Kissa win World 25K Kolkata; India's Gulveer makes course record
- US accounts for 18 per cent of Indian exports in FY24
Covaxin, Covishield get regular market approval
Covaxin, Covishield get regular market approval
- Now, the 2 Covid vaccines will be available in hospitals, clinics
- However, the vaccines cannot be sold at medical stores
New Delhi: The Drugs Controller General of India's (DCGI) on Thursday granted regular market approval for Covid-19 vaccines Covaxin and Covishield for use in adult population, sources said. The vaccines, however, will not be available at medical stores.
As per certain conditions set by the drug regulator, hospitals and clinics can purchase vaccines and the vaccination data has to be submitted to the DCGI every six months and updated on the CoWIN app.
Under the said conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting. Monitoring of adverse event following immunisation will be continued. The DCGI's approval came after the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) on January 19 recommended granting regular market approval to the Serum Institute of India's (SII's) Covishield and Bharat Biotech's Covaxin for use in adult population subject to certain conditions.
"The CDSCO has now upgraded the permission for Covaxin and Covishield from restricted use in emergency situations to normal new drug permission in the adult population with certain conditions," Union Health Minister Mansukh Mandaviya said on Thursday.
